Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM5A | P29375 | 9/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 8/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 4/20 | 0.33 |
| ▸ | KDM4A | O75164 | 2/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14690418 | 0.90 | KDM5A (0.33) | KDM5AKDM4CPHF8KDM4ACNR2 | |
| SCHEMBL2455260 | 0.84 | EPHX2 (0.35) | CNR2EPHX2ALDH1A1 | |
| SCHEMBL272291 | 0.84 | KDM4C (0.37) | KDM5AKDM4CPHF8KDM4ACNR2 | |
| SCHEMBL272810 | 0.84 | KDM4C (0.37) | KDM5AKDM4CPHF8KDM4ACNR2 | |
| SCHEMBL14690061 | 0.84 | L3MBTL1 (0.32) | SRD5A1L3MBTL1 | |
| SCHEMBL14702025 | 0.81 | ALDH1A1 (0.33) | EPHX2ALDH1A1 | |
| SCHEMBL9378729 | 0.79 | L3MBTL1 (0.31) | SRD5A1L3MBTL1 | |
| SCHEMBL9351981 | 0.76 | EPHX2 (0.36) | CNR2EPHX2 | |
| SCHEMBL16939131 | 0.76 | PDE3B (0.31) | ALDH1A1 | |
| SCHEMBL2462031 | 0.76 | DGKA (0.34) | CNR2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150210828-A1 | STERICALLY HINDERED AMINES | BASF SE (DE) | 2015-07-30 | — | — | US | disclosed |
| US-9045430-B2 | Sterically hindered amines | BASF SE (DE) | 2015-06-02 | — | — | US | disclosed |
| EP-2542526-B1 | Sterically hindered amines | BASF SE (DE) | 2015-05-13 | — | — | EP | disclosed |
| US-20130041076-A1 | STERICALLY HINDERED AMINES | BASF SE (DE) | 2013-02-14 | — | — | US | disclosed |
| EP-2542526-A1 | STERICALLY HINDERED AMINES | BASF SE (DE) | 2013-01-09 | — | — | EP | disclosed |
| WO-2011107513-A1 | STERICALLY HINDERED AMINES | BASF SE (DE) | 2011-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150210828-A1 | STERICALLY HINDERED AMINES | CCNA1, C5, H1-0 | KDM5A 942/4885KDM4C 1217/4885PHF8 1088/4885 |
| US-20130041076-A1 | STERICALLY HINDERED AMINES | CCNA1, C5, H1-0 | KDM5A 942/4885KDM4C 1217/4885PHF8 1088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.